SG
ABBV icon

Strid Group’s AbbVie ABBV Stock Holding History

Strid Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.4M Sell
11,022
-20
-0.2% -$4.44K 0.3% 23
2025
Q4 		$2.52M Buy
11,042
+20
+0.2% +$4.56K 0.31% 23
2025
Q3 		$2.55M Buy
11,022
+2
+0% +$407 0.32% 23
2025
Q2 		$2.05M Buy
+11,020
New +$2.05M 0.29% 22

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Strid Group's ABBV Position: Q1 2026 in Review

Strid Group reduced its AbbVie (ABBV) stake by 0.18% in Q1 2026, selling an estimated $4.44K and leaving 11,022 shares worth $2.4M. The position accounts for 0.3% of the portfolio, ranked #23.

Strid Group first reported a position in ABBV in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.55M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Strid Group held 11,022 shares of AbbVie worth $2.4M as of Q1 2026.
  • Strid Group sold 20 AbbVie shares in Q1 2026, an estimated $4.44K.
  • AbbVie made up 0.3% of Strid Group's portfolio in Q1 2026, its #23 holding.
  • Strid Group first reported a position in AbbVie in Q2 2025 and has held it in 4 quarters since.
  • Strid Group's AbbVie position peaked at $2.55M in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Strid Group's 13F filing for Q1 2026, filed 29 Apr 2026.